Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate MiniMed Group, Inc. before investing.
In this article, we go over a few key elements for understanding MiniMed Group, Inc.’s stock price such as:
- MiniMed Group, Inc.’s current stock price and volume
- Why MiniMed Group, Inc.’s stock price changed recently
- Upgrades and downgrades for MMED from analysts
- MMED’s stock price momentum as measured by its relative strength
About MiniMed Group, Inc. (MMED)
Before we jump into MiniMed Group, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
Want to learn more about MiniMed Group, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about MiniMed Group, Inc..
MiniMed Group, Inc.’s Stock Price as of Market Close
As of July 31, 2026, 4:00 PM, CST, MiniMed Group, Inc.’s stock price was $18.050.
MiniMed Group, Inc. is down 0.52% from its previous closing price of $18.145.
During the last market session, MiniMed Group, Inc.’s stock traded between $17.660 and $18.230. Currently, there are approximately 268.10 million shares outstanding for MiniMed Group, Inc..
MiniMed Group, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.
MiniMed Group, Inc. Stock Price History
MiniMed Group, Inc.’s (MMED) price is currently up 20.74% so far this month.
During the month of July, MiniMed Group, Inc.’s stock price has reached a high of $18.670 and a low of $14.700.
Over the last year, MiniMed Group, Inc. has hit prices as high as $20.482 and as low as $10.650.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused MiniMed Group, Inc. Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded MiniMed Group, Inc.’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate MiniMed Group, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on MiniMed Group, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
MiniMed Group, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about MiniMed Group, Inc. (MMED) by visiting AAII Stock Evaluator.
Relative Price Strength of MiniMed Group, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of July 30, 2026, MiniMed Group, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.
Want to learn more about how MiniMed Group, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
MiniMed Group, Inc. Stock Price: Bottom Line
As of July 31, 2026, MiniMed Group, Inc.’s stock price is $18.050, which is down 0.52% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like MiniMed Group, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.